Pfizer (PFE)

R&D Expense Growth

11.53%

Fiscal year · Period ending:

PFE logo

PFE R&D Expense Growth

Latest reported11.53%
PFE FY R&D Growth (YoY) (0.00% → 11.53%)
High-resolution chart · PNG

PFE r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
11.5291%
1.5126%
-7.4217%
-17.3706%
47.1847%
12.3266%
4.9831%
4.2119%
-2.4872%
2.2031%
-7.6895%
26.8509%
-5.8088%
-13.1059%
-14.4689%
20.6861%
3.2215%
-0.8055%
2.0207%
3.0114%
-5.4331%
6.8574%
37.7705%
6.7877%
9.2897%
59.7622%
21.8078%
18.2054%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.